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Developmental signals determine organ morphology and position during embryogenesis. To discover
novel modiﬁers of liver development, we performed a chemical genetic screen in zebraﬁsh and identiﬁed
retinoic acid as a positive regulator of hepatogenesis. Knockdown of the four RA receptors revealed that
all receptors affect liver formation, however speciﬁc receptors exert differential effects. Rargb knockdown
results in bilateral livers but does not impact organ size, revealing a unique role for Rargb in conferring
left–right positional information. Bilateral populations of hepatoblasts are detectable in rargbmorphants,
indicating Rargb acts during hepatic speciﬁcation to position the liver, and primitive endoderm is
competent to form liver on both sides. Hearts remain at the midline and gut looping is perturbed in rargb
morphants, suggesting Rargb affects lateral plate mesoderm migration. Overexpression of Bmp during
somitogenesis similarly results in bilateral livers and midline hearts, and inhibition of Bmp signaling
rescues the rargb morphant phenotype, indicating Rargb functions upstream of Bmp to regulate organ
sidedness. Loss of rargb causes biliary and organ laterality defects as well as asplenia, paralleling
symptoms of the human condition right atrial isomerism. Our ﬁndings uncover a novel role for RA in
regulating organ laterality and provide an animal model of one form of human heterotaxia.
& 2012 Elsevier Inc. All rights reserved.Introduction
During embryogenesis, the liver develops asymmetrically across
the left–right axis. In human heterotaxic syndromes, misalignment of
the visceral organs is often associated with cardiac defects and
impaired bile duct formation and typically requires surgical inter-
vention. Liver development originates in the endoderm where
hepatic progenitors are speciﬁed from a multipotent precursor
population. Expression of liver-speciﬁc transcription factors in a
select population of endodermal cells is in part regulated by
surrounding mesodermal tissues which provide inductive cues
required for proper liver development and positioning. Many of
these signaling pathways have been independently characterized,
however the sequence and integration of genetic networks regulat-
ing liver development have not been well established.
In zebraﬁsh, hepatoblasts are speciﬁed in the endodermal rod
by 24 hours post-fertilization (hpf), and between 24–28 hpf, thell rights reserved.
nt of Medicine, Brigham and
8, Boston, MA 02115, USA.
. North),gut begins to loop to the left, concordant with asymmetrical
movements of the lateral plate mesoderm (LPM) (Field et al.,
2003; Horne-Badovinac et al., 2003; Ober et al., 2003). Although
the importance of mesoderm–endoderm signaling during liver
development has been highlighted previously (Chung et al., 2008;
Ober et al., 2006; Reiter et al., 1999, 2001; Shin et al., 2007), it is
not clear how many of these developmental signals intersect
during hepatic speciﬁcation and positioning.
Evidence that retinoic acid (RA) signaling is involved in endo-
derm formation ﬁrst surfaced in a study of pancreatic speciﬁcation
in zebraﬁsh (Stafford and Prince, 2002). Global inhibition of
zebraﬁsh RARs resulted in reduced or absent expression of endo-
crine and exocrine pancreas markers as well as hhex, a hepatic
transcription factor. Analysis of zebraﬁsh raldh2 mutants (neckless,
aldh1a2um22, aldh1a2i26) also revealed similar disruptions in endo-
derm development (Alexa et al., 2009; Stafford and Prince, 2002).
Despite these studies, the function of a number of integral RA
pathway members, including raldh3 and raldh4, and the impact of
individual RARs on liver development remain unknown.
RA signaling has been further suggested to affect organ laterality.
Early studies have demonstrated that inhibition of RA signaling or
addition of excess RA leads to randomized heart looping in mice
(Chazaud et al., 1999), and vitamin A deﬁcient avian embryos develop
reversed heart situs (Dersch and Zile, 1993), thereby suggesting a role
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mechanism by which RA regulates organ positioning has not been
elucidated. LPM movements impact visceral organ positioning
(Horne-Badovinac et al., 2001; Huang et al., 2008; Yin et al., 2010),
suggesting that RA signaling may exert its effect on organ laterality
via regulation of LPM migration.
In this study, we deﬁne the role of RA signaling during liver
speciﬁcation and positioning. In a large-scale chemical genetic
screen, we identiﬁed RA as a regulator of normal liver develop-
ment. We demonstrate that both RA synthesis and receptor-
mediated signaling impact stages of hepatic speciﬁcation, differ-
entiation, and proliferation. We show for the ﬁrst time that raldh4
impacts liver development following hepatic speciﬁcation. Raraa,
rarab, and rarga knockdowns lead to smaller livers, whereas rargb
knockdown results in bilateral livers, demonstrating receptor-
speciﬁc effects on liver development. The heart and gut remain at
the midline in rargb morphants, indicative of a left–right pattern-
ing defect, however Nodal signaling is unaffected in these
embryos. We observe that transient upregulation of Bmp signal-
ing also results in midline hearts and bilateral livers. Inhibition of
Bmp signaling rescues the bilateral liver defect in rargb mor-
phants, suggesting that RA normally inhibits Bmp signaling
during organ laterality determination, and we indeed ﬁnd that
rargb knockdown results in elevated levels of phosphorylated
Smads 1/5/8 in the developing embryo. Rargb morphants also
develop bile duct defects and asplenia, and this phenotype
parallels the human heterotaxic syndrome right atrial isomerism,
or Ivemark syndrome (Ivemark, 1955), in which patients display a
midline heart, midline or duplicated livers, biliary atresia, and
asplenia. These results suggest that proper RA signaling may be
required for situs solitus of human organs.Materials and methods
Zebraﬁsh husbandry
Zebraﬁsh were maintained according to IACUC protocols. LF2.8-
EGFP referred to as Lfabp:GFP; (Her et al., 2003), cmlc2:GFP (Huang
et al., 2003), cyp26a1:eYFP (Hu et al., 2008), miles apart (mil)
(Kupperman et al., 2000), hs:bmp2b (Chocron et al., 2007),
BRE:eGFP (Laux et al., 2011) and tp1bglob:eGFP (Parsons et al.,
2009) transgenic and mutant lines have been described previously.
Chemical exposures
Zebraﬁsh embryos were exposed to 0.1 mM all-trans retinoic
acid (ATRA, Sigma), 1.0 mM 4-diethylaminobenzaldehyde (DEAB,
Sigma), 1.0 mM AGN193109 (Toronto Research Chemicals),
1.0 mM MM11253 (Tocris), 25 mM dorsomorphin, or 0.1 mM
CD1530 (Tocris) during the speciﬁed time windows. Stock solu-
tions were diluted in E3 embryo water. Control embryos were
concurrently exposed to 0.1% DMSO. After chemical exposure,
embryos were washed 3–5 in E3 solution then ﬁxed with 4%
PFA at the appropriate stages. The chemical genetic screen was
performed as described previously (North et al., 2007). Wild type
age-matched embryos were arrayed into 48-well plates and
exposed to test compounds from 18–72 hpf. Compound libraries
used include the NINDS Custom Collection (1040 compounds),
SpecPlus Collection (960) and BIOMOL ICCB Known Bioactives
(480).
Whole mount in situ hybridization
Zebraﬁsh embryos were ﬁxed in 4% PFA at the speciﬁed stages,
and in situ hybridization was performed according to establishedprotocols (http://zﬁn.org/ZFIN/Methods/ThisseProtocol.html) using
the following probes: (Endoderm) lfabp, prox1, foxA3, shh; (heart)
cmlc2, amhc, vmhc; (spleen) hox11; (kidney) slc20a1a, slc12a3;
(thyroid) nkx2.1a; (LPM) hand2; (Nodal) spaw, pitx2, lefty1, lefty2;
(Bmp) smad1, smad4, smad 5. The number of embryos displaying
a particular phenotype is presented as a percentage of the sample
size, n.
Whole mount immunostaining
BrdU: Zebraﬁsh embryos were incubated in 10 mM BrdU on
ice for 20 min at 24 hpf, returned to warm embryo water for
5 min, then ﬁxed in 4% PFA. Embryos were incubated with anti-
BrdU primary (Roche) and goat anti-mouse peroxidase-conju-
gated secondary (Jackson ImmunoResearch) antibodies and visua-
lized with DAB. BrdUþ cells were counted manually in a deﬁned
region of the embryo (n¼5 embryos/chemical treatment).
2F11: Zebraﬁsh larvae were ﬁxed at 5 dpf and incubated in a
1:500 dilution of mouse monoclonal 2F11 primary antibody
(Abcam) followed by 1:50 FITC rabbit anti-mouse IgG secondary
antibody (Jackson ImmunoResearch).
Morpholino knockdown and mRNA rescue injections
Morpholinos (MOs; GeneTools) were designed against zebra-
ﬁsh raldh2 (50 CAACTTCACTGGAGGTCATCGCGTC 30) (100 mM) and
raldh4 (50 GATATTTCATGTCTTTTGACATCGC 30) (200 mM), and
previously published MOs were used against RA receptors raraa,
rarab, rarga, and rargb (400–800 mM) (Linville et al., 2009). For the
RARg rescue experiment, 200 pg mouse Rarg mRNA (OriGene
Technologies) was co-injected with 400 mM rargb MO at the
1-cell stage.
Flow cytometry analysis
Lfabp:GFP ﬂuorescent embryos were exposed to chemicals or
injected with MOs as described above, whole embryos were
manually dissociated in 0.9 PBS, and %GFPþ cells were deter-
mined by ﬂow cytometric analysis. Z20,000 cells were analyzed
per embryo, and Z5 embryos were analyzed for each chemical
treatment or MO injection using FlowJo software.
Microscopy
Live ﬂuorescence microscopy was performed on cmlc2:GFP,
BRE:eGFP, or tp1bglob:eGFP embryos anesthetized in 0.04 mg/ml
Tricaine in E3 embryo water using a Zeiss Discovery V8 micro-
scope. Once sorted by phenotype, embryos were washed several
times and returned to E3 for further observation and/or until
ﬁxation. Embryos used in in situ hybridization or BrdU immunos-
taining experiments were visualized in glycerol. Confocal micro-
scopy of 2F11 immunostained embryos was performed on a Zeiss
LSM 510 Meta microscope. For each treatment group, images
presented are shown at the same magniﬁcation. Scale bars repre-
sent 100 mm unless otherwise noted.
Smad Western blots
Protein lysates were isolated at 18 hpf from control, rargb
morphant, and dorsomorphin-treated embryos by manual dis-
ruption in RIPA buffer. 1:1000 anti-pSmad/1/5/8 (Cell Signaling
Technology) or 1 mg/ml anti-Smad 1/5/8/9 (Cayman Chemical)
primary antibody was used, followed by 1:3000 anti-rabbit HRP
secondary antibody (Abcam).
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A chemical genetic screen identiﬁes retinoic acid signaling as a
regulator of liver development
To identify novel regulators of liver development, we conducted
a chemical genetic screen in zebraﬁsh (Fig. S1). We exposed wild
type or lfabp:GFP ﬂuorescent reporter embryos to a library of
known bioactive compounds over the course of liver development
(18–72 hpf) and scored embryonic liver size at 72 hpf by in situ
hybridization or ﬂuorescence microscopy, respectively. Com-
pounds having an effect on liver development were grouped by
mechanism of action. Out of 2640 compounds tested, 135 (5.1%)
increased liver size, whereas 229 (8.7%) decreased liver size.
We identiﬁed a number of molecular pathways that impact liver
growth, including retinoic acid (RA) signaling. In particular, our
screen uncovered eight hits corresponding to six compounds that
affect RA signaling: vitamin A, all-trans retinoic acid (ATRA),
isotretinoin, beta carotene, and the RA synthesis inhibitors diethy-
laminobenzaldehyde (DEAB) and disulﬁram.Fig. 1. Retinoic acid signaling enhances embryonic liver development. (A–F) In situ hybr
at 18 hpf. ATRA treatment leads to greater lfabp expression, whereas DEAB treatment l
(G–I) Fluorescence microscopy of lfabp:GFP reporter ﬁsh at 72 hpf conﬁrms in situ hybr
ﬁsh at 72 hpf demonstrates changes in RA signaling activity in chemically treated embr
24 hpf embryos demonstrates that ATRA-treated embryos show higher levels of prolif
treated controls. (M0–O0) Enlarged images of (M–O) illustrating individual proliferating
(black rectangle in O). (Q) FACS quantiﬁcation of percent GFPþ cells in chemically treate
and DEAB-treated embryos contain fewer hepatocytes than DMSO-treated controls. (
marker transferrin in ATRA and DEAB-treated embryos at 72 hpf compared to DMSO-tre
100 mm.To corroborate our chemical screen ﬁndings and to determine
the stage at which RA impacts liver development, we treated
embryos with RA pathway compounds during speciﬁc time
windows targeting hepatoblast speciﬁcation (18–24 hpf), hepato-
blast differentiation (24–48 hpf), and hepatocyte proliferation
(48–72 hpf). At all time points, embryos treated with ATRA
develop bigger livers, whereas embryos treated with DEAB or
AGN193109, a pan-RAR inhibitor, develop smaller livers as
determined by lfabp in situ hybridization (Figs. 1A–F and S2(A)
and (B)) and GFP expression in live lfabp:GFP reporter embryos
(Fig. 1G–I) at 72 hpf. These results suggest that RA signaling is
important throughout all stages of hepatic speciﬁcation, differ-
entiation, and proliferation. RA pathway inhibitors DEAB and
AGN193109 were most penetrant during the earliest treatment
window (18–24 hpf), with 50% of embryos developing smaller
livers (DEAB: n¼136; AGN193109: n¼25). To conﬁrm that our
drug treatments impact RA signaling in the embryo, we treated
cyp26a1:eYFP reporter ﬁsh with ATRA or DEAB at 18 hpf. Cyp26a1
promotes degradation of RA and is induced by RA in an auto-
regulatory feedback loop (White et al., 1996; Abu-Abed et al.,idization for lfabp at 72 hpf reveals differences in liver size after chemical exposure
eads to reduced lfabp expression. First row, lateral view. Second row, dorsal view.
idization results in (A–F). (J–L) Fluorescence microscopy of cyp26a1:eYFP reporter
yos. Arrowheads highlight the liver. (M–O) BrdU whole mount immunostaining of
eration in the liver primordium (black rectangle) compared to DEAB and DMSO-
cells in the liver primordium. (P) Quantiﬁcation of the number of BrdUþ cells/ﬁeld
d lfabp:GFP embryos reveals that ATRA-treated embryos contain more hepatocytes
R) qPCR analysis reveals differences in the relative expression of the hepatocyte
ated controls (where control expression levels were normalized to 1.0). Scale bars:
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cyp26a1:eYFP embryos with ATRA led to increased ﬂuorescence
throughout the embryo, with particularly increased intensity in
the brain and liver, whereas DEAB treatment decreased ﬂuores-
cence in these regions (Fig. 1J–L). These results demonstrate that
RA signaling is active in the embryonic liver and is modulated by
chemical exposure.
To determine whether changes in liver size in chemically treated
embryos are related to changes in hepatic cell proliferation, we
assessed BrdU incorporation at 24 hpf. We found that proliferation
levels correspond to liver size: ATRA-treated embryos have more
BrdUþ cells, and DEAB and AGN193109-treated embryos contain
fewer BrdUþ cells (Fig. 1M–O). Quantiﬁcation of BrdUþ cells in the
area of the liver primordium (Fig. 1O box, magniﬁed in 1M0–O0 0)
revealed a signiﬁcant decrease in proliferating hepatic cells in DEAB
(n¼5, t-test, p¼0.001) (Fig. 1P) and AGN193109-treated embryos
(n¼5, t-test, p¼0.006) (Fig. S2(C)) and an increase in BrdUþ cells in
ATRA-treated embryos compared to DMSO controls. We veriﬁed
these changes in hepatic cell proliferation by performing FACS at
72 hpf on lfabp:GFP embryos exposed to RA pathway compounds
from 18–24 hpf. Quantiﬁcation of GFPþ cells uncovered signiﬁcant
changes in hepatocyte number in compound-treated embryos com-
pared to controls (DMSO versus ATRA p¼2.0105, DEAB p¼8.6
105, AGN193109 p¼0.0002; ATRA versus DEAB p¼4.6108, AGN
p¼1.1106; DEAB versus AGN p¼0.69) (Figs. 1Q and S2(D)).
TUNEL analysis conﬁrmed that changes in liver size are not related
to hepatic cell death (data not shown). qPCR analysis of embryos
exposed to RA pathway compounds further demonstrated that liver
size and hepatocyte number correlate with expression levels of the
hepatocyte marker transferrin at 72 hpf, indicating that the observed
changes are not speciﬁc for lfabp (Fig. 1R) (DMSO versus ATRA:
p¼0.02; versus DEAB: 0.07; ATRA versus DEAB p¼0.01). Together,
these results demonstrate that RA signaling enhances embryonic liver
growth.
Retinaldehyde dehydrogenase (Raldh) enzymes are responsible
for converting retinaldehyde to RA. The zebraﬁsh expresses three
Raldhs – raldh2, raldh3, and raldh4 (Begemann et al., 2001; Liang
et al., 2008; Pittlik et al., 2008). Raldh2 is expressed in the lateral
plate mesoderm during somitogenesis, and zebraﬁsh and medaka
raldh2 mutants display defective liver development (Begemann
et al., 2001; Alexa et al., 2009; Negishi et al., 2010). Raldh3 is
expressed in the eye and is therefore unlikely to have a role in liver
development. Raldh4 is expressed in the developing liver at 48 hpf
(Liang et al., 2008), however targeted knockdown of raldh4 has not
been reported. To determine whether Raldh4 is required for normal
liver development and whether its temporal requirement is distinct
from that of Raldh2, we knocked down raldh2 and raldh4 using ATG
start site morpholinos (MOs). Liver size was subsequently assessed
by in situ for prox1 at 30 and 48 hpf and lfabp at 72 hpf. At 30 hpf,
100% of raldh2 knockdown embryos and 4% of raldh4 knockdown
embryos developed small livers compared to 6% in controls (nZ25/
condition) (Fig. 2A–C). Similarly, at 48 hpf, 7% of control embryos,
100% of raldh2 morphants, and 17% of raldh4 morphants developed
small livers (nZ18/condition) (Fig. 2D–F). When examined at
72 hpf, 0% of control embryos, 80% of raldh2 morphants, and 82%
of raldh4 morphants developed small livers (nZ40/condition)
(Fig. 2G–I). Our results indicate that raldh2 is required throughout
hepatogenesis, whereas raldh4 is primarily required following hepa-
tocyte speciﬁcation (after 48 hpf). Additionally, in a separate experi-
ment in which we titered individual MO doses to prevent toxicity
from double MO injection, we found that 0% of uninjected embryos,
31% of raldh2 morphants, 21% of raldh4 morphants, and 76% of
raldh2þ4 double morphants developed small livers at 72 hpf
(nZ14/condition). These data suggest that Raldh2 and 4 enzymes
act sequentially and synergistically during hepatogenesis and cor-
roborate our timed chemical exposure studies.Retinoic acid signaling impacts liver size and laterality by
receptor-speciﬁc mechanisms
The zebraﬁsh expresses two RA receptor (RAR) a subtypes,
raraa and rarab, and two RARg subtypes, rarga and rargb (Hale
et al., 2006). No RAR b has been identiﬁed to date. Combinatorial
RAR knockdowns result in defects in hindbrain, limb, and phar-
yngeal arch development (Linville et al., 2009), but receptor-
speciﬁc roles in liver development have not been described. To
elucidate individual receptor contributions to hepatogenesis, we
knocked down each receptor using previously published MOs
(Linville et al., 2009). Knockdown of RARs aa, ab, and ga, primarily
resulted in smaller livers (raraa: 43% smaller livers, n¼28; rarab:
15%, n¼34; rarga: 47%, n¼38) (Fig. 3A–D and G–J), suggesting that
these receptors act redundantly during hepatic speciﬁcation and/or
hepatocyte proliferation. Interestingly, we found that knockdown
of rargb caused embryos to develop bilateral livers (29%, n¼105)
(Fig. 3E and K), suggesting that this receptor regulates liver
laterality. Combinatorial knockdown of all four RARs resulted in
even smaller (82%), sometimes absent livers (18%, n¼22), indicat-
ing that RARs are required for normal hepatic speciﬁcation (Fig. 3F
and L). These results are corroborated by the fact that single RAR
knockout mice are viable, whereas double knockouts display a
number of developmental defects (Mark et al., 2006).
To conﬁrm our rargb knockdown results chemically, we treated
embryos with a selective RARg antagonist, MM11253, over the
course of hepatogenesis (18–72 hpf). Whereas DMSO controls
developed left-sided livers, 24% (n¼33) of MM11253-treated
embryos developed bilateral livers (Fig. 3M and N), conﬁrming
our MO knockdown results. Additionally, bilateral livers developed
in embryos treated during shorter, early time windows (18–24
and 24–48 hpf) (Fig. 3O and P), suggesting that Rargb exerts its
effect during hepatic speciﬁcation. FACS quantiﬁcation of RAR
MO-injected Lfabp:GFP reporter ﬁsh at 72 hpf demonstrated that
rargb morphants with two livers have signiﬁcantly more hepato-
cytes than their control siblings, whereas raraa knockdown
embryos have fewer GFPþ hepatocytes than control siblings, and
combinatorial knockdown embryos fewer still (Fig. 3Q) (rargb MO
versus control, p¼0.00017; versus raraa MO, p¼0.00023; versus
combo MO, p¼2.40106). These data illustrate that individual
RARs have speciﬁc effects on liver speciﬁcation and laterality.
To further elucidate the timing of rargb’s effect on liver
laterality, we injected rargb MO and assessed hepatic bud forma-
tion at 30 hpf using the hepatoblast marker prox1 and at 48 hpf
using the pan-endodermal marker foxA3. Whereas control
embryos displayed left-sided liver buds at 30 hpf, 26% of rargb
morphants (n¼23) developed bilateral populations of hepato-
blasts (Fig. 4A and B). This percentage corresponds to the number
of bilateral livers seen at 72 hpf (29%). We also observed that
some rargb morphants display midline liver buds at 30 hpf (21%,
n¼23). We did not observe midline livers at 72 hpf in rargb
morphants, suggesting that midline populations of hepatoblasts
ultimately resolve into unilateral hepatocyte populations or split
into two liver buds. These results corroborate our early (18–24,
24–48 hpf) MM11253 treatments, demonstrating that rargb
knockdown impacts liver laterality during hepatic speciﬁcation.
Examination of foxA3 expression at 48 hpf further conﬁrmed that
rargb knockdown leads to bilateral livers (Fig. 4C and D). In
control embryos, the pan-endodermal marker foxA3 marks the
left-sided liver and right-sided pancreas. In rargb morphants, we
identiﬁed bilateral livers in 30% of MO-injected embryos (n¼28).
We also discovered that in some cases, embryos with bilateral
livers also developed bilateral pancreata (7%, n¼28). Whereas
most bilateral livers occurred in the presence of a normal right-
sided pancreas, bilateral pancreata always occurred in conjunc-
tion with bilateral livers (Fig. 4D). These results demonstrate that
Fig. 2. Raldhs 2 and 4 temporally regulate liver development. (A–I) Wild type embryos were injected with raldh2 or raldh4 MO at the 1-cell stage, and liver development
was assessed over the next 72 h. In situ hybridization for the hepatoblast marker prox1 at 30 hpf (A–C) and 48 hpf (D–F) and hepatocyte marker lfabp at 72 hpf (G–I)
demonstrates distinct temporal requirements for Raldh2 and Raldh4 during liver development. Arrowheads denote the liver primordium, and the dotted lines outline the
liver. Scale bars: 100 mm.
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endoderm derivatives.
Rargb knockdown affects organ laterality
In zebraﬁsh, cardiac progenitors develop bilaterally, coalesce at
the midline, then the nascent heart tube jogs asymmetrically to the
left of the midline around 1 dpf (Bakkers et al., 2009). In mice, the
cardiac mesoderm and septum transversum mesenchyme provide
Fgf and Bmp signals to specify hepatic progenitors in the overlying
endoderm (Jung et al., 1999; Rossi et al., 2001), and loss of these
signals in zebraﬁsh prevents hepatic speciﬁcation (Shin et al., 2007).
It is therefore possible that defective heart positioning and ectopic
inductive cues precede the development of bilateral livers. We have
observed the coincidence of heart and liver laterality defects in other
contexts; double in situ hybridization for hepatoblast and cardiac
markers prox1 and cmlc2, respectively, revealed that cardia biﬁda
mutants miles apart (mil) (Kupperman et al., 2000) also develop
bilateral livers (Fig. S3). Accordingly, to determine whether laterality
defects in the endoderm are accompanied by heart jogging defects,
we examined expression of the pan-cardiomyocyte marker cmlc2 at
26 hpf. Control embryos developed left-sided heart tubes, whereas33% of rargb morphants displayed midline heart tubes (n¼33)
(Fig. 5A and D). Knockdowns of RARs raraa, rarab, and rarga did
not affect heart jogging (data not shown). Examination of chamber
speciﬁc markers atrial and ventricular myosin heavy chain (amhc and
vmhc, respectively) revealed that the ventricle is speciﬁcally affected
by rargb knockdown (36%, n¼28) (Fig. 5B, C, E and F). We also
conﬁrmed our genetic results chemically by treating embryos with
the selective RARg antagonist MM11253 over the course of cardiac
jogging (14–26 hpf) and examining cmlc2 expression at 26 hpf.
MM11253-exposed embryos also displayed heart jogging defects
(25%, n¼24) (Fig. 5G and H), further indicating that loss of rargb
perturbs heart laterality.
Just as zebraﬁsh rargb morphants develop midline ventricles,
dominant negative RARgE305 chimeric mice exhibit misaligned or
unlooped ventricles (Iulianella and Lohnes, 2002), suggesting that
RARg functions similarly during vertebrate organogenesis. To demon-
strate evolutionary conservation of RARg function during cardiac
development, we performed a rescue experiment in which zebraﬁsh
rargbMO was co-injected with mouse RargmRNA at the 1-cell stage,
and vmhc expression was evaluated at 30 hpf. Compared to controls
(0% midline ventricles, n¼20), 35% (n¼34) of rargb morphants
developed amidline ventricle (control versusMO p¼0.0019), whereas
Fig. 3. Retinoic acid receptors differentially impact liver development and laterality. (A–L) Lfabp expression at 72 hpf in RAR morphant embryos. Loss of RARs raraa, rarab,
and rarga leads to a reduction in liver size (A–D and G–J), whereas loss of rargb causes embryos to develop bilateral livers (E, K and K0). Embryos simultaneously injected
with a lower dose of all four RAR MOs develop small livers or none at all (F and L). (M–P) Embryos treated with the RARg antagonist MM11253 over the time points given
develop bilateral livers, conﬁrming genetic knockdown data. (Q) FACS quantiﬁcation of percent GFPþ cells in lfabp:GFP RAR morphant embryos reveals that rargb
morphant embryos with bilateral livers contain signiﬁcantly more GFPþ hepatocytes than control siblings. Embryos injected with raraa, rarab, rarga, and rargb in
combination have roughly half as many GFPþ hepatocytes as control embryos. Scale bars: 100 mm.
Fig. 4. Rargb knockdown impacts the left–right asymmetry of visceral organs. (A and B) Prox1 expression demonstrates that hepatic progenitors normally migrate to the
left of the midline at 30 hpf (A, black arrowhead). Loss of rargb results in bilateral (B) or midline (B0) hepatoblast populations. (C-D) In situ hybridization for the pan-
endodermal marker foxA3 at 48 hpf demonstrates that loss of rargb results in bilateral livers (black arrowheads) that are sometimes accompanied by bilateral pancreata
(white arrowheads). (E and F) Rargb morphants develop gut looping abnormalities (arrow), as demonstrated by shh expression at 48 hpf (E and F). (G and H) Hand2
expression at 48 hpf demonstrates aberrant LPM migration in rargb morphants (H). Insets in (G and H) highlight the differences in LPM phenotypes. Scale bars: 100 mm.
M.K. Garnaas et al. / Developmental Biology 372 (2012) 178–189 183only 9% (n¼22) of MOþmRNA co-injected embryos displayed this
defect (MO versusMOþmRNA p¼0.0315) (Fig. 5I). We also examined
lfabp expression at 72 hpf to determine whether mouse Rargb mRNArescues the rargb morphant liver phenotype. All controls developed
left-sided livers (n¼23), whereas 22% (n¼41) of rargb morphants
(control versus MO p¼0.0208) and 10% (n¼30) of MOþmRNA
Fig. 5. Midline hearts and bilateral livers correlate in rargbmorphants. (A–F) Control embryos develop leftward jogging hearts as shown by the pan-cardiomyocyte marker
cmlc2 at 26 hpf (A) and chamber-speciﬁc markers vmhc and amhc at 30 hpf (B and C), whereas rargb morphants develop midline ventricles (D and E). (G and H) Embryos
treated with the RARg antagonist MM11253 develop midline hearts, conﬁrming genetic knockdown data. (I) RARg function is evolutionarily conserved. The midline heart
phenotype of rargbmorphant embryos is rescued by injection of mouse RargmRNA. (J) Midline hearts and bilateral livers correlate in the same embryo. Cmlc2:GFP reporter
ﬁsh injected with rargb MO were sorted by heart phenotype at 30 hpf, then liver laterality was assessed at 72 hpf by lfabp expression. Scale bars: 100 mm.
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p¼0.218). Although we consistently see a reduction in the number
of bilateral livers in co-injected embryos, we suspect that the rescue is
less effective at a later stage due to persistent toxicity from the
presence of two exogenous nucleotide constructs. Together, our
results demonstrate that RARg function is conserved between ﬁsh
and mammals.
To demonstrate that heart and endoderm defects are linked in
the same embryo, we injected rargb MO into cmlc2:GFP reporter
ﬁsh, sorted embryos by heart phenotype (left or midline) at 30 hpf
by ﬂuorescence microscopy, and assessed lfabp expression by
in situ at 72 hpf. If heart and liver defects correlate in the same
embryo, this would suggest a unifying underlying cause (e.g., gut
looping defect) or that one defect precedes the other (e.g., alteredcardiac asymmetry governs liver positioning). We found that heart
and liver defects are signiﬁcantly correlated in the same embryo
(po0.0001, Chi-squared analysis). Speciﬁcally, whereas only 10%
of embryos with a left-sided heart developed bilateral livers
(n¼71), 74% of embryos with a midline heart developed bilateral
livers (n¼31) (Fig. 5J). Together, our results demonstrate that rargb
knockdown impacts heart (ventricle) as well as endoderm later-
ality and suggest that these phenotypes are linked.
Because rargbmorphants develop endoderm and cardiac defects,
we reasoned that this might be due to an underlying cause such
as aberrant LPM migration. Failed gut looping is often associated
with bilateral endodermal organs (Chen et al., 2001), and zebraﬁsh
mutant for the bHLH transcription factor hand2 exhibit failed LPM
migration and develop gut looping defects and bilateral livers and
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whether gut looping is affected in rargb morphants by observing
expression of sonic hedgehog (shh) and hand2 at 48 hpf. We found
that the gut, which normally loops leftward in control embryos, did
not loop or remained at the midline in rargb morphant embryos
(shh: 29% midline, 54% weak looping, n¼24; hand2: 73%, n¼22)
(Fig. 4E–H). We tested additional markers for the thyroid, hypotha-
lamus, and kidney (nkx2.1a, slc20a1a, slc12a3) and did not note any
defects (data not shown), indicating that rargb knockdown impacts
only a subset of mesendodermal organs.
Nodal signaling is unaffected in rargb morphants
Nodal signaling is a master regulator of left–right asymmetry
(Shen, 2007). Nodal signals originating in the node propagate
anteriorly in the left LPM and impact endoderm and heart
asymmetry. To determine whether laterality defects seen in rargb
morphants are due to altered Nodal signaling, we examined the
expression of the zebraﬁsh Nodal signal southpaw (spaw), down-
stream effector pitx2, and Nodal antagonists lefty1 and lefty2
during somitogenesis (18–22 somites). Both control and rargb
morphant embryos displayed normal left-sided expression of
spaw, pitx2, and lefty2, and the molecular midline barrier lefty1
remained intact (Fig. S4), demonstrating that Rargb’s impact on
organ laterality is Nodal-independent. We also treated embryos
with the RARg antagonist MM11253 in two time windows
targeting early development, 32 cell-2 somite and 2 somite-
20 hpf, and found that Nodal signals remain left-sided in 91%
(n¼66) and 92% (n¼51) of these embryos, respectively. The
results of these chemical exposures further demonstrate that
inhibition of rargb during early development does not impact
Nodal signaling. It was recently shown that LPMmigration defects
in hand2 mutants are not due to Nodal defects alone; in spaw
morphants, the direction of LPM migration is randomized,
whereas in hand2 mutants, LPM migration does not occur at all
(Yin et al., 2010). Furthermore, although previous studies have
suggested that early inhibition of RA signaling (prior to the
2 somite stage) affects Nodal signaling, these embryos ultimately
develop situs inversus rather than duplicated or midline organs
(Huang et al., 2011), bolstering our observations that rargb
morphant defects are likely due to defects in LPM migration
rather than misexpression of global laterality signals.
Rargb affects Bmp signaling via altered phospho-Smad levels during
organ laterality determination
Bmp4 is expressed asymmetrically in the left LPM between
20–22 somites, and this expression pattern leads to greater
activation of phosphorylated Smads on the left side and is
correlated with leftward cardiac jogging (Chen et al., 1997;
Chocron et al., 2007; Smith et al., 2008). Because Bmp signaling
is important for determining heart laterality, we investigated
whether ectopic Bmp signaling perturbs liver laterality. We heat
shocked inducible hs:bmp2b zebraﬁsh embryos at 12 somites,
prior to cardiac jogging and hepatic speciﬁcation, and examined
heart and liver development by in situ for cmlc2 (30 hpf) and lfabp
(72 hpf), respectively. At 30 hpf, 5% (n¼100) of non heat shocked
(hs) control sibling embryos and 72% (n¼79) of heat shocked
embryos (hsþ) displayed midline hearts (Fig. 6A). Similarly, at
72 hpf, 4% (n¼106) of hs embryos compared to 33% (n¼111)
of hsþ embryos developed bilateral livers (Fig. 6B). These data
demonstrate that rargb knockdown and bmp2b overexpression
result in the same phenotype, suggesting interplay between RA
and Bmp signaling during laterality determination.
Given that loss of rargb or gain of bmp2b expression results in
bilateral livers and midline hearts, we hypothesized that RA signalingantagonizes Bmp signaling during organ development (or vice
versa). To determine whether RA inhibits Bmp signaling, we
injected rargb MO at the 1-cell stage then treated these embryos
with the Bmp inhibitor dorsomorphin from 14–17 hpf. At 72 hpf,
we assessed whether Bmp inhibition rescued rargb morphants’
bilateral liver phenotype. Whereas 3% of uninjected/DMSO-treated
control embryos (n¼101) and 1% of uninjected/dorsomoprhin-
treated embryos (n¼137) developed bilateral livers, 24% of rargb
MO-injected/DMSO-treated embryos developed bilateral livers
(n¼144; p-valueo0.0001 for MO/DMSO versus uninjected/
DMSO). In contrast, 17% of rargb MO/dorsomorphin-treated
embryos (n¼163) developed bilateral livers (Fig. 6C; p-value¼
0.1565 for MO/DMSO versus MO/dorsomorphin). These results
represent six independent experiments in which the same rescue
trend was noted in each. Together, these results demonstrate that
inhibition of Bmp signaling rescues the rargb morphant pheno-
type and suggesting that Bmp acts downstream of Rargb during
laterality determination.
We also performed the reverse experiment by ﬁrst over-
expressing Bmp then treating embryos with a RARg agonist,
CD1530. Hs:bmp2b transgenic embryos were heat-shocked at 12
somites then treated with CD1530 from 16–18 somites, and liver
development was assessed at 72 hpf by lfabp expression. Whereas
hs/CD1530 and hs/CD1530þ embryos did not display later-
ality defects, 25% of both hsþ/CD1530 and hsþ/CD1530þ
embryos (nZ13/condition) developed bilateral livers (data not
shown). These data further indicate that Rargb acts upstream of
Bmp signaling to govern organ laterality.
Our in vivo data suggest that loss of rargb leads to an increase
in Bmp signaling, since loss of rargb and overexpression of bmp2b
result in the same laterality defects, and inhibition of Bmp
signaling by dorsomorphin rescues the rargb morphant pheno-
type. To corroborate our in vivo ﬁndings, we examined expression
levels of phosphorylated Smad1/5/8 (p-Smads), cytoplasmic
effectors of Bmp signaling, in whole embryo lysates at 18 hpf.
We found that rargb knockdown led to a 60% increase in
p-Smad1/5/8 expression levels compared to control embryos by
Western blot analysis (Fig. 6D). Whereas expression patterns of
Bmp-related smads 1/5 as well as that of co-Smad smad4 are
unchanged at the level of in situ hybridization (data not shown),
total levels of Smad 1/5/8/9 proteins are also increased in rargb
morphants as determined by Western blot analysis, indicative of
decreased degradation (Fig. S5). Together, our results indicate that
Rargb normally inhibits Bmp signaling by reducing levels of active
cytoplasmic Bmp effectors p-Smad1/5/8.
In addition to examining p-Smad1/5/8 levels in embryo lysates,
we also investigated whether changes in Bmp signaling were visible
in the cardiac ﬁeld of living embryos using transgenic Bmp response
element reporter ﬁsh BRE:eGFP that are responsive to Smad1/5
activity (Laux et al., 2011). In wild type embryos, Bmp signaling is
active asymmetrically (Smith et al., 2008), with greater signaling
occurring in the left LPM around the 20–22 somite stage, leading to
a leftward jogging heart tube by 24 hpf. Compared to control
embryos that displayed asymmetric Bmp activity (100%; 6 left,
1 right), 53% of rargb morphant embryos (n¼15) exhibited symme-
trical Bmp activity at 22 somites (Fig. 6E and F). We examined these
same embryos at 30 hpf to assess whether changes seen in Bmp
signaling at 22 somites ultimately affected heart tube development.
Because Bmp remains active in the heart at this stage, the direction
of cardiac jogging can be assessed in BRE:eGFP embryos. Both control
and rargb morphant embryos’ hearts jogged according to earlier
sidedness of Bmp activity. Speciﬁcally, all control embryos devel-
oped asymmetrically jogged hearts (6 left, 1 right; 100% asymme-
trical), whereas 40% of rargb morphant embryos developed midline
hearts (6 midline, 7 left, 2 right; 60% asymmetrical) (Fig. 6G and H;
p-value¼0.0225 for control versus rargb morphant embryos
Fig. 6. Rargb negatively regulates Bmp activity and localization in vivo. (A and B) Overexpression of Bmp in heat shock inducible hs:bmp2b embryos results in midline
hearts (A) and bilateral livers (B), paralleling the phenotype of rargbmorphants. (C) Treatment of rargbmorphant embryos with the Bmp inhibitor dorsomorphin results in
a reduction in the number of bilateral livers compared to DMSO-treated control rargb morphants. (D) Western blot for Bmp effectors phospho-Smads 1/5/8 in uninjected
control (Un) and rargb MO-injected embryos (MO) at 18 hpf. Band density values normalized to Actin demonstrate that loss of rargb results in increased expression of
p-Smads 1/5/8. Embryos treated with the Bmp inhibitor dorsomorphin (DM) show reduced p-Smad 1/5/8 expression compared to DMSO-treated controls. (E–H)
Fluorescence microscopy of Bmp response element reporter ﬁsh BRE:eGFP. At 20 hpf, control embryos display greater Bmp activity on the left side (E), whereas rargb
morphants display symmetrical Bmp activity (F). Altered Bmp localization at 20 hpf corresponds to heart laterality defects at 36 hpf in rargb morphants (H). White dotted
lines denote the midline (E and F) or outline the heart tube (G and H). Scale bars: 100 mm.
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signaling). Correspondingly, we also found that control embryos
displayed normal asymmetric expression of bmp4 around the cardiac
cone, whereas bmp4 expression is symmetrical in rargbmorphants as
determined by in situ hybridization at 21 somites (Fig. S6(D) and (E)).
Together, these results demonstrate in vivo that loss of rargb affects
Bmp activity and ultimately organ laterality.
The zebraﬁsh rargb morphant phenotype resembles human right
atrial isomerism
Rargb morphant laterality defects are strikingly similar to the
human heterotaxic syndromes left or right atrial isomerism in
which patients display both a midline heart and a duplicated or
midline liver (Sutherland and Ware, 2009; Zhu et al., 2006). Biliary
atresia, characterized by blocked or absent hepatic bile ducts, is
another hallmark of the human heterotaxic condition (Sutherland
and Ware, 2009) so we investigated whether rargb morphants also
display biliary defects. We ﬁrst examined tp1bglob:eGFP reporter
ﬁsh in which the Epstein–Barr Virus TP1 gene, placed upstream of
the rabbit b-globin minimal promoter acts as a Notch-responsive
element (Parsons et al., 2009). Notch signaling is required for
normal bile duct speciﬁcation and development and highlights the
biliary tree as early as 76 hpf (Lorent et al., 2010; Lorent et al.,
2004). Compared to control larvae that developed intrahepatic bile
ducts with a normal latticework appearance, 56% (n¼52) of rargb
MO-injected larvae exhibited dysmorphic bile duct architecturecharacterized by reduced intrahepatic branching and connectivity
(Fig. 7A and B). In addition to examining bile duct development
in vivo in Notch reporter ﬁsh, we also investigated the expression
of the bile duct cell marker 2F11 (Crosnier et al., 2005) by whole
mount immunostain in 5 dpf larvae. Confocal projections of control
embryos revealed a regular, highly branched network of intrahe-
patic bile ducts, whereas rargb morphant embryos displayed less
extensive ductular networks and enlarged cell bodies at duct
junctions (84%, n¼19) (Fig. 7C–F), defects reminiscent of the
human pathophysiology of biliary atresia. The etiology of biliary
atresia remains unknown, however our results suggest that loss of
rargb negatively impacts bile duct formation.
Patients with heterotaxia often exhibit asplenia or polyspenia
(Ivemark, 1955; Sutherland and Ware, 2009), so we also investi-
gated whether rargb morphants develop spleen defects by exam-
ining expression of hox11 at 5 dpf. 34% (n¼58) of rargb morphants
had a small or absent spleen, compared to only 3% of control
embryos (n¼33, p-value¼0.0005), suggesting that loss of rargb
results in a phenotype similar to human asplenia. Patients with
right atrial isomerism, or Ivemark syndrome, typically display
apslenia (Ivemark, 1955) whereas patients with left atrial isomer-
ism predominantly develop polyspenia (Zhu et al., 2006), thus the
rargb morphant phenotype more closely resembles right atrial
isomerism. Together, the laterality, biliary, and spleen defects seen
in rargb morphants implicate RARg in human heterotaxic syn-
dromes and suggest that RA signaling is important for situs solitus
of human organs.
Fig. 7. Rargb morphants develop biliary defects. (A and B) Fluorescence microscopy of Notch reporter ﬁsh tp1bglob:eGFP at 5 dpf. Rargb morphant embryos develop
defective bile duct architecture (B, arrows) compared to the normal latticework appearance of the control embryo’s biliary tree (A). (C–F) Confocal microscopy of 2F11
whole mount immunostained embryos at 5 dpf. Rargb morphant embryos display enlarged cell bodies (D and E, white arrowheads) and reduced branching of intrahepatic
bile duct networks (F) compared to control embryos (C). White dotted lines outline the liver. Images are taken at the same magniﬁcation. (G–I) In situ hybridization for
hox11 at 5 dpf. Rargb morphants display small (H) or absent (I) spleens compared to control embryos (G). Black arrowheads denote the spleen. Scale bars: 50 mm.
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In this study, we identiﬁed RA as a regulator of zebraﬁsh
hepatogenesis and elucidated roles for RA signaling in organdevelopment and positioning. We have shown that RA synthesis by
Raldh enzymes and downstream signal transduction by RARs are
both important for proper liver development. RAR knockdowns reveal
that individual receptors exert speciﬁc effects during organogensis.
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unlooped guts, and epistasis analyses demonstrate that Rargb func-
tions upstream of Bmp to affect organ positioning. Rargb morphants
also develop bile duct defects and asplenia, which in combination
with their laterality phenotypes, parallel the human heterotaxic
syndrome right atrial isomerism.
It has been suggested that RA signaling is involved in endoderm
development (Stafford and Prince, 2002; Alexa et al., 2009; Negishi
et al., 2010), however roles for speciﬁc RARs in liver development
and positioning have not been described. Our ﬁnding that one
receptor, Rargb, impacts organ laterality can be explained by
differences in zebraﬁsh RAR expression patterns and divergent
RAR phylogenies (Waxman and Yelon, 2007). First, rargb is located
on a different chromosome than rarga, suggesting that these may
be different genes rather than splice variants. Furthermore,
whereas rarga is not expressed maternally, rargb is expressed both
maternally and zygotically. Phylogenetic analyses have also estab-
lished that rargb is more closely related to mouse and human
RARG, supporting our results demonstrating evolutionary conser-
vation of RARg function. Knockdown of the RA transport protein
Rbp4 results in the formation of two liver buds (Li et al., 2007),
corroborating a role for RA signaling in liver progenitor positioning.
Although Nodal is known to be a master regulator of left–right
asymmetry (Shen, 2007), we did not ﬁnd its expression affected
by loss of rargb. It has previously been shown that blocking RA
signaling before the 2 somite stage alters Nodal signaling in
zebraﬁsh (Huang et al., 2011), but organs are primarily reversed
rather than duplicated or midline in these embryos. Furthermore,
studies in other species have suggested that RA signaling can impact
organ laterality without disrupting early left–right signals. In
Xenopus, laterality defects manifest in embryos treated with DEAB
after Nodal has established the left–right axis (Lipscomb et al.,
2006), and Raldh2 null mice develop unlooped hearts despite Nodal
being unaffected (Niederreither et al., 2001). Characterization of the
zebraﬁsh mutant heart and soul (has), which displays failed gut
looping and symmetrical visceral organs (Horne-Badovinac et al.,
2001), revealed that these laterality defects are accompanied by
normal spaw and pitx2 expression (Horne-Badovinac et al., 2003),
further suggesting that left–right patterning defects can manifest in
the presence of normal Nodal signaling.
RA and Bmp signals intersect in other developmental contexts
(Sheng et al., 2010; Shimono et al., 2011; Song et al., 2007; Tehrani
and Lin, 2011), so we hypothesized that RA may exert its effect on
organ development by regulating Bmp activity. In mice, Bmps
generated adjacent to the cardiac mesoderm in the septum trans-
versum mesenchyme induce hepatic progenitors in the nearby
endoderm and promote outgrowth of the liver primordium (Jung
et al., 1999; Rossi et al., 2001). Studies in mice and chick have
demonstrated that RARG inhibits Bmp signaling by promoting
degradation of phosphorylated Smad (Sheng et al., 2010; Shimono
et al., 2011), further substantiating our ﬁnding that RA integrates
with Bmp signaling via regulation of Bmp’s downstream effectors.
Loss of rargb results in laterality defects of the liver, heart, and
gut, but it is unclear whether all defects are linked. Gut looping
occurs around 30 hpf (Horne-Badovinac et al., 2003), but we observe
heart jogging defects as early as 26 hpf; accordingly, abnormal LPM
migration can only account for visceral organ but not heart defects. It
is possible that aberrant RA signaling affects both LPMmigration and
local Bmp signaling around the cardiac cone, thereby affecting
multiple organs. It has recently been shown that zebraﬁsh RARs
primarily act as transcriptional activators rather than repressors
(Waxman and Yelon, 2011), so it is also possible that rargb may
preferentially activate another molecule on the right side that
normally acts as a repressor of the hepatic fate. No tail (ntl), ﬂoating
head (ﬂh), and schmalspur (sur) mutants display midline hearts, loss
of gut looping, and duplication of visceral organs, and it has beensuggested that because these are loss-of-function mutations, the
normally asymmetric liver results from suppression of hepatic
activators on the right side (Chen et al., 2001). A previous study
suggests that rargb is asymmetrically expressed in the neural crest
cells of the hindbrain at 18 hpf (Linville et al., 2009), however rargb
appears to be expressed equally on both left and right sides of the
trunk during somitogenesis (Fig. S6(A)), so it remains unclear how
rargb exerts its affect on visceral organ laterality. It is possible that
in situ hybridization is not sensitive enough to detect slight asym-
metries in rargb expression that may impact downstream signaling.
Organ laterality and bile duct defects exhibited by rargb mor-
phants are reminiscent of the human pathological condition right
atrial isomerism in which patients display midline hearts, midline or
duplicated livers, biliary atresia, and asplenia. Our data suggest that
perturbed RA signaling may play a role in human heterotaxia and
furthermore, that heterotaxia can result from mutations in genes
other than Nodal. We demonstrate that loss of Rargb and Bmp
overexpression result in the same organ laterality defects, where
Rargb functions upstream of Bmp signaling to regulate organ position,
and that Rargb also impacts biliary development. Biliary abnormal-
ities often result in obstructed bile ﬂow, leading to pancreatitis and
jaundice, and necessitate surgical intervention or liver transplantation
in infants (Davenport, 2005; Haber and Russo, 2003). The etiology of
biliary atresia remains unknown, but the fact that rargb morphants
and left or right atrial isomerism patients develop organ situs and
biliary defects suggests a common underlying mechanism. By under-
standing the role of RA and Bmp signaling in organ development and
positioning, we may be able to better understand and treat patients
with these life-threatening malformations.Acknowledgments
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